The Corner

Adult Stem-Cell Success in MS

This treatment to reverse MS isn’t “new.” It has been in human trials for years — and continues to look very hopeful. How hopeful? From the Telegraph story:

The treatment is being carried out at Royal Hallamshire Hospital in Sheffield and Kings College Hospital, London and involves use a high dose of chemotherapy to knock out the immune system before rebuilding it with stem cells taken from the patient’s own blood.

Miss Drewry had the treatment in Sheffield. She said: “I started seeing changes within days of the stem cells being put in.

“I walked out of the hospital. I walked into my house and hugged Isla. I cried and cried. It was a bit overwhelming. It was a miracle.”

Her treatment has now been reviewed and her condition found to have been dramatically halted. She will need to be monitored for years but the hope is that her transplant will be a permanent fix.:

Let us hope so. And we need to keep in mind that this is still in the testing stage. Time will tell if it enters medicine’s armamentarium.

But it’s also worth recalling that during the embryonic-stem-cell debate in the Bush years, Big Biotech and their media and camp followers repeatedly claimed emphatically that embryonic stem cells were the “only hope” for diseases like MS, and that those who suggested that there were ethical alternatives were “anti-science” and “imposing religion on science.” Bah.

Remember that the next time “the scientists” try to stampede you into accepting — and paying hundreds of billions for — questionably ethical approaches to finding CURES! CURES! CURES!

Wesley J. Smith — Wesley J. Smith is a senior fellow at the Discovery Institute’s Center on Human Exceptionalism.

Most Popular


Trump and the North Korean Tipping Point

The world has been stunned by North Korean dictator Kim Jong Un’s announcement last week that he was suspending his country’s nuclear tests in preparation for the impending meeting with President Trump. Even critics have had to concede that Trump’s bellicose rhetoric since last summer regarding the North ... Read More

Hurray for the NBA

Last month, just before the Final Four, I did a Q&A on college basketball with our Theodore Kupfer. Teddy K. is back, by popular demand, joined by two other experts: Vivek Dave, an old friend of mine from Michigan, who has long lived in Chicago, and David French, National Review’s Kentucky Kid, now ... Read More
Economy & Business

Trade Misunderstandings

I was distracted by other policy topics last week but not enough not to notice Peter Navarro’s article in the Wall Street Journal, headlined “China’s Faux Comparative Advantage.” Considering Navarro’s position in the White House, it is unfortunate that it demonstrates some serious misunderstandings ... Read More